All News

BiTE therapy could lead to better ways to target the immune system, while minimizing the chance of resistance.

Reaching a younger age group of African American men for prostate cancer detection may improve their survival outcomes, says an expert from the University of California San Diego.

Treatment with the combination of Stivarga and Bavencio was associated with minor anti-tumor activity in patients with advanced, heavily pretreated biliary tract solid tumors.

Treatment with pyrotinib and the chemotherapies trastuzumab, docetaxel and carboplatin significantly improved response rates over the triplet chemotherapy regimen alone in the neoadjuvant treatment of patients with HER2-positive breast cancer.

A cancer survivor describes how oncology nurses have had a deep impact on her during treatment.

First immunotherapy, intralesional therapy, is making a comeback and producing durable remissions for a subgroup of patients with cancer.

Experts urge patients to stop playing the wait-and-see game: There’s no ‘playbook’ for immunotherapy-related toxicities, and side effects can be managed if caught early.

CNN’s chief international anchor announced her ovarian cancer diagnosis live on-air today, which she wants everyone to use as a call to arms for all people to undergo cancer screening.

To avoid the financial burden of costly therapies, patients with cancer receiving immunotherapy treatments should talk with their health care team and not settle for no as an answer from their health insurance provider, according to an expert.

A cancer survivor describes how hearing about a friend’s cancer diagnosis brings emotions to the surface.

The vaccine significantly improved a survival outcome over standard-of-care treatment in patients with newly diagnosed glioblastoma.

From physical therapy for pain to an emergency room visit ending up in a cancer diagnosis, a patient describes her experience with an oncology nurse with whom she attributes a positive recovery experience.

A cancer survivor shares five ways that caregivers can provide support.

A patient wrote about the smile and hug he received every time he went for a doctor’s visit, in addition to the wealth of information she provided whenever he had questions related to his cancer.

A caregiver describes the imprint her daughter’s oncology nurses left on her heart.

A mother describes how an administrator was able to help connect her and her son to the care that he needed for fibrolamellar carcinoma.

A patient describes her experience with a nurse shortly after her breast cancer surgery, which involved relocation to another facility.

A patient describes her experience with a nurse who had the ability to make patients feel like they’re not in the cancer center receiving treatment with her humor and cheerfulness.

“All women with breast cancer deserve quality health care,” writes one survivor. “But for an incarcerated woman, that care may not come in a timely manner, if at all.”

From an emotional "America’s Got Talent” audition from a singer with cancer to a wig company that creates wigs for women of color, here’s what’s happening in the cancer landscape this week.

Treatment with an investigational drug induced high response rates in patients with relapsed or refractory multiple myeloma.

A combination of treatment with bladder-saving surgical resection, Opdivo and chemotherapy yielded positive results in patients with muscle-invasive bladder cancer.

Use of the combination of Keytruda and Inlyta is associated with long-term survival benefits in patients with kidney cancer.

A woman with metastatic breast cancer describes a recent zip lining adventure she took with her dad, who is a cancer survivor.

In this episode of the “CURE® Talks Cancer” podcast, author Steve Kelley shares both the painful and positive moments of his journey with a rare cancer.

Treatment with this combination was associated with encouraging clinical responses in this patient population.

Introducing integrated palliative care to patients with a certain type of leukemia was shown to facilitate active coping strategies, which could improve a patient’s quality of life.

Maintenance treatment with Lynparza plus Avastin over Avastin alone provided a certain group of patients with ovarian cancer a substantial survival benefit.